High cost of new cancer drugs may lead to lower medical adherence

05/23/2011 | Wall Street Journal, The

Spending to treat cancer is likely to rise 15% annually through 2013, according to Medco's Drug Trend Report, primarily due to more expensive drugs. Some 10% of patients already fail to fill new prescriptions for oral cancer treatments, according to a study by Avalere Health and The West Clinic, and higher drug costs could lead to higher prescription abandonment rates. The study authors suggest that policymakers find ways to minimize out-of-pocket costs for low-income patients.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC